Pathology: Page 50

VELscope sales boost LED Medical 2011 revenues
By DrBicuspid.com staff writers
LED Medical Diagnostics, makers of the VELscope oral cancer screening device and parent company of LED Dental, reported record revenues for 2011 (end-December 31) and expects to see this trend continue in 2012.
April 2, 2012
OC survivor urges tax increase for smokeless tobacco
By Donna Domino
Gruen von Behrens recently testified at a Maryland legislative hearing urging lawmakers to increase the tax on smokeless tobacco. The motivational speaker says chewing tobacco nearly ruined his life after he developed squamous cell carcinoma at the age of 17 and had half of his tongue and neck muscles removed.
April 2, 2012
2012 04 03 08 37 18 947 Gruen Von Behrens 70
Aspen Dental supports Oral Cancer Awareness Month
By DrBicuspid.com staff writers
In honor of Oral Cancer Awareness Month this month, 340 Aspen Dental practices in 22 states will donate $5 from every Vizilite Plus screening conducted in April to the Oral Cancer Foundation.
April 1, 2012
Virus could treat head/neck cancer
By DrBicuspid.com staff writers
A naturally occurring, harmless human virus may boost the effects of two standard chemotherapy drugs in some cancer patients, according to new data published in Clinical Cancer Research.
April 1, 2012
Oral carcinogen ID'd in smokeless tobacco
By DrBicuspid.com staff writers
A chemical present in smokeless tobacco products is a strong oral carcinogen, according to research being presented this week at the American Association for Cancer Research's annual meeting in Chicago.
April 1, 2012
Metformin may lower risk for oral cancer
By DrBicuspid.com staff writers
Metformin may protect against oral cancer, according to a new study in Cancer Prevention Research.
April 1, 2012
FDA takes action to address tobacco epidemic
By DrBicuspid.com staff writers
The U.S. Food and Drug Administration (FDA) has released two separate draft guidance documents to help fight the tobacco epidemic and prevent children from using tobacco.
March 29, 2012
Study questions TBlue accuracy in detecting oral dysplasia
By Donna Domino
Toluidine blue (TBlue) is a useful adjunct to visual exams for the detection of oral cancers in the dental office. But a new study in Oral Diseases questions whether it is sensitive enough to detect oral epithelial dysplasias that often precede these cancers.
March 29, 2012
2010 06 21 15 17 35 214 Question Mark 70
Nanoparticles kill head/neck cancer cells in mice
By DrBicuspid.com staff writers
Using nanoparticles and alternating magnetic fields, University of Georgia scientists have found that head and neck cancerous tumor cells in mice can be killed in half an hour without harming healthy cells.
March 27, 2012
Drug reduces lymph node surgery in head/neck cancer patients
By DrBicuspid.com staff writers
Data from a Phase III clinical trial of 99m-Tc-Tilmanocept, also known as Lymphoseek (Navidea Biopharmaceuticals) in oral and squamous cell cancers (SCC) suggest it may be improve surgical treatment of patients with head and neck SCC (HNSCC).
March 27, 2012
FDA panel finds dissolvable tobacco less risky
By DrBicuspid.com staff writers
A U.S. Food and Drug Administration (FDA) advisory panel report released March 21 says dissolvable tobacco products could reduce health risks compared with other tobacco products.
March 22, 2012
Chef, cancer survivor drops dental malpractice lawsuits
By DrBicuspid.com staff writers
Renowned chef Grant Achatz has reached an undisclosed settlement with Bucktown Wicker Park Dental Associates, the Chicago-area dental clinic he sued after being diagnosed with advanced tongue cancer, according to a story in the Chicago Sun-Times.
March 22, 2012
Previous Page
Page 50 of 87
Next Page